지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Unfortunately, the five-year survival rate of lung cancer is relatively low compared with other cancers. Therefore, better predictors are need for prognosis, therapeutic strategy, risk stratification and predicting long-term mortality of lung cancer. Recently, increasing data suggest that Glasgow Prognostic Score (GPS) and procalcitonin levels are useful predictor cancer prognosis. In this study, we retrospectively investigated the correlation of GPS or procalcitonin to clinical variables in patients with pretreatment lung cancer. In 135 patients with pretreatment lung cancer, GPS, procalcitonin, demographic characteristics, hematological, coagulation, biochemical, inflammatory and cardiac markers were measured. Monocyte, eosinophil, basophil, neutrophil to lymphocyte ratio, red cell distribution width (RDW), platelet to lymphocyte ratio, mean platelet volume to platecrit ratio, D-dimer and prothrombin time (PT) levels were higher, whereas mean platelet volume was lower than their normal ranges. Glucose and sodium levels were low, whereas gamma glutamyl transferase (GGT), total bilirubin, creatinine and inorganic phosphorus concentrations were increase compared their normal ranges. Procalcitonin, high sensitivity C-reactive protein and troponin-I concentrations were elevated compared with their normal ranges. GPS had significantly positive or negative relations to cancer stage, hematological, coagulation, biochemical, inflammatory and troponin-I. Based on the data, we suggest that GPS may be a potent and useful predictor for prognosis, therapeutic strategy, risk stratification and predicting long-term mortality of lung cancer.
목차
IINTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (41)
참고문헌 신청
Akinbami A, Popoola A, Adediran A, Dosunmu A, Oshinaike O, Adebola P. Full blood count pattern of pre-chemotherapy breast cancer patients in Lagos, Nigeria. Caspian J Intern Med. 2013. 4: 574-579.
Albayrak S, Zengin K, Tanik S, Bakirtas H, Imamoglu A, Gurdal M. Red cell distribution width as a predictor of prostate cancer progression. Asian Pac J Cancer Prev. 2014. 15: 7781-7784.
Anthony HM. Blood basophils in lung cancer. Br J Cancer 1982. 45: 209-216.
Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost. 1992. 18: 353-372.
Cassetta L, Pollard JW. Cancer immunosurveillance: role of patrolling monocytes. Cell Res. 2015. 144: Epub ahead of print.
Albayrak S, Zengin K, Tanik S, Bakirtas H, Imamoglu A, Gurdal M. Red cell distribution width as a predictor of prostate cancer progression. Asian Pac J Cancer Prev. 2014. 15: 7781-7784.
Anthony HM. Blood basophils in lung cancer. Br J Cancer 1982. 45: 209-216.
Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost. 1992. 18: 353-372.
Cassetta L, Pollard JW. Cancer immunosurveillance: role of patrolling monocytes. Cell Res. 2015. 144: Epub ahead of print.
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Epidemiology of Lung Cancer in Korea: Recent Trends
Tuberculosis and Respiratory Diseases
2016 .01
-
Higher Age Puts Lung Cancer Patients at Risk for Not Receiving Anti-cancer Treatment
Cancer Research and Treatment
2019 .01
-
Risk Factors for Lung Cancer Mortality in a Referral Center
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Clinical Usefulness of Human Epididymis Protein 4 in Lung Cancer
Annals of Laboratory Medicine
2017 .01
-
폐암 정복을 위한 전방위적 반격
대한의사협회지
2023 .03
-
국가 폐암 검진
대한내과학회지
2020 .04
-
Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry
Tuberculosis and Respiratory Diseases
2019 .01
-
Risk of Coronavirus Disease Incidence, Severe Presentation, and Mortality in Patients with Lung Cancer
Cancer Research and Treatment
2021 .01
-
폐암의 바이오마커와 진단도구
대한의사협회지
2021 .01
-
ERRATUM : Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry
Tuberculosis and Respiratory Diseases
2019 .01
-
Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015
Tuberculosis and Respiratory Diseases
2018 .01
-
Characteristics and Prediction of Lung Cancer Mortality in China from 1991 to 2013
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Gene mutation discovery research of non-smoking lung cancer patients due to indoor radon exposure
대한직업환경의학회지
2016 .03
-
Study on Theoretical Models of Regional Humanity Lung Cancer Hazards Assessment
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Expression of potassium channel genes predicts clinical outcome in lung cancer
The Korean Journal of Physiology & Pharmacology
2019 .01
-
Lung Cancer in a Rural Area of China: Rapid Rise in Incidence and Poor Improvement in Survival
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014
Cancer Research and Treatment
2019 .01
-
비소세포폐암의 새로운 표적치료
대한의사협회지
2023 .03
-
EDITORIAL : Staging Work-up for Early Lung Cancer: The More the Better?
Tuberculosis and Respiratory Diseases
2017 .01
-
The Development of the Korean Lung Cancer Registry (KALC-R)
Tuberculosis and Respiratory Diseases
2019 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2016-510-002777168